Syncope in the Athletic Patient

Progress in Cardiovascular Diseases

Volumn 54, Issue 5, 2012, Pages 438-444

  Hastings, Jeffrey L ^a,b   Levine, Benjamin D ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Cardiac pathology; Exercise; Syncope

Indexed keywords

ANAMNESIS; ARTICLE; ATHLETE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; COLLAPSE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; HEART ELECTROPHYSIOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; LABORATORY TEST; PATIENT EDUCATION; PATIENT SAFETY; PHYSICAL EXAMINATION; PRESYNCOPE; PREVALENCE; SPORT; SYNCOPE; TILT TABLE TEST; WELLBEING;

ATHLETES; DEATH, SUDDEN, CARDIAC; EXERCISE; HUMANS; PHYSICAL ENDURANCE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SYNCOPE;

EID: 84857590315     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.02.003     Document Type: Article

References (48)

1. Calkins H., Seifert M., Morady F. Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope. Am Heart J 1995, 129:1159-1164.
2. Maron B.J. Sudden death in young athletes. N Engl J Med 2003, 349:1064-1075.
3. Driscoll D.J., Jacobsen S.J., Porter C.J., et al. Syncope in children and adolescents. J Am Coll Cardiol 1997, 29:1039-1045.
4. Strickberger S.A., Benson D.W., Biaggioni I., et al. AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation 2006, 113:316-327.
5. Calkins H., Zipes D.P. Hypotension and syncope. Heart Disease 2005, 909-919. Saunders, Philadelphia, PA. D.P. Zipes, P. Libby, R.O. Bonow, E. Braunwald (Eds.).
6. Freeman R., Wieling W., Axelrod F.B., et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci 2011, 161:46-48.
7. O'Connor F.G., Levine B.D., Childress M.A., et al. Practical management: a systematic approach to the evaluation of exercise-related syncope in athletes. Clin J Sport Med 2009, 19:429-434.
8. Link M.S., Estes N.A. How to manage athletes with syncope. Cardiol Clin 2007, 25:457-466. vii.
9. Colivicchi F., Ammirati F., Santini M. Epidemiology and prognostic implications of syncope in young competing athletes. Eur Heart J 2004, 25:1749-1753.
10. Freeman R., Wieling W., Axelrod F.B., et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 2011, 21:69-72.
11. Holtzhausen L.M., Noakes T.D., Kroning B., et al. Clinical and biochemical characteristics of collapsed ultra-marathon runners. Med Sci Sports Exerc 1994, 26:1095-1101.
12. Casey D.P., Joyner M.J. Local control of skeletal muscle blood flow during exercise: influence of available oxygen. J Appl Physiol 2011, 111:1527-1538.
13. Rowell L.D. Human cardiovascular control 1993, Oxford University Press, New York.
14. Campagna J.A., Carter C. Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology 2003, 98:1250-1260.
15. O'Connor F.G., Oriscello R.G., Levine B.D. Exercise-related syncope in the young athlete: reassurance, restriction or referral?. Am Fam Physician 1999, 60:2001-2008.
16. Levine B.D., Buckey J.C., Fritsch J.M., et al. Physical fitness and cardiovascular regulation: mechanisms of orthostatic intolerance. J Appl Physiol 1991, 70:112-122.
17. Levine B.D., Lane L.D., Buckey J.C., et al. Left ventricular pressure-volume and Frank-Starling relations in endurance athletes. Implications for orthostatic tolerance and exercise performance. Circulation 1991, 84:1016-1023.
18. Basso C., Maron B.J., Corrado D., et al. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000, 35:1493-1501.
19. Hobbs J.B., Peterson D.R., Moss A.J., et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. Jama 2006, 296:1249-1254.
20. Corrado D., Basso C., Thiene G., et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997, 30:1512-1520.
21. Maron B.J., Shirani J., Poliac L.C., et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. Jama 1996, 276:199-204.
22. Kapoor W.N. Current evaluation and management of syncope. Circulation 2002, 106:1606-1609.
23. Loeys B.L., Dietz H.C., Braverman A.C., et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010, 47:476-485.
24. Maron B.J., Araujo C.G., Thompson P.D., et al. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2001, 103:327-334.
25. Maron B.J., Thompson P.D., Ackerman M.J., et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007, 115:1643-1655.
26. Corrado D., Pelliccia A., Heidbuchel H., et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010, 31:243-259.
27. Pelliccia A., Maron B.J., Culasso F., et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000, 102:278-284.
28. Lawless C.E., Best T.M. Electrocardiograms in athletes: interpretation and diagnostic accuracy. Med Sci Sports Exerc 2008, 40:787-798.
29. Bahr R. Can electrocardiographic screening prevent sudden death in athletes? No. BMJ 2010, 341:c4914.
30. Brown J.L., Hirsh D.A., Mahle W.T. Use of troponin as a screen for chest pain in the pediatric emergency department. Pediatr Cardiol 2012, 33:337-342.
31. Maron B.J., Doerer J.J., Haas T.S., et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009, 119:1085-1092.
32. Zipes D.P., Ackerman M.J., Estes N.A., et al. Task Force 7: arrhythmias. J Am Coll Cardiol 2005, 45:1354-1363.
33. The European Society of Cardiology guidelines for the diagnosis and management of syncope reviewed by Angel Moya, MD, FESC, Chair of the Guideline Taskforce with J. Taylor, MPhil. Eur Heart J 2009, 30:2539-2540.
34. Rockx M.A., Hoch J.S., Klein G.J., et al. Is ambulatory monitoring for "community-acquired" syncope economically attractive? A cost-effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring. Am Heart J 2005, 150:1065.
35. Paisey J.R., Yue A.M., Treacher K., et al. Implantable loop recorders detect tachyarrhythmias in symptomatic patients with negative electrophysiological studies. Int J Cardiol 2005, 98:35-38.
36. Moya A., Brignole M., Menozzi C., et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 2001, 104:1261-1267.
37. Morillo C.A., Dillenburg R., Guzman J.C. To tilt or not to tilt: what is the question?. Clin Auton Res 2004, 14:360-362.
38. Raviele A., Menozzi C., Brignole M., et al. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 1995, 76:267-272.
39. Morillo C.A., Klein G.J., Zandri S., et al. Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995, 129:901-906.
40. Kapoor W.N., Brant N. Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 1992, 116:358-363.
41. Brooks R., Ruskin J.N., Powell A.C., et al. Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 1993, 71:1289-1292.
42. Childress M.A., O'Connor F.G., Levine B.D. Exertional collapse in the runner: evaluation and management in fieldside and office-based settings. Clin Sports Med 2010, 29:459-476.
43. Childs H., Friedrich M.G. Cardiovascular magnetic resonance imaging in myocarditis. Prog Cardiovasc Dis 2011, 54:266-275.
44. Karamitsos T.D., Francis J.M., Neubauer S. The current and emerging role of cardiovascular magnetic resonance in the diagnosis of nonischemic cardiomyopathies. Prog Cardiovasc Dis 2011, 54:253-265.
45. Crean A. Cardiovascular MR and CT in congenital heart disease. Heart 2007, 93:1637-1647.
46. Maron B.J., Zipes D.P. Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol 2005, 45:1318-1321.
47. Safety of Sports for Patients With Implantable Cardioverter-Defibrillators. ClinicalTrials.gov Accessed Feb 07, 2012, at. http://clinicaltrials.gov/ct2/show/NCT00637754.
48. Heidbuchel H. Implantable cardioverter defibrillator therapy in athletes. Cardiol Clin 2007, 25:467-482. vii.